OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $37,000 | -19.6% | 86,470 | +4.9% | 0.00% | – |
| Q1 2016 | $46,000 | -78.8% | 82,470 | -19.9% | 0.00% | -100.0% |
| Q3 2015 | $217,000 | -56.2% | 102,970 | +3.0% | 0.00% | -50.0% |
| Q2 2015 | $495,000 | -39.0% | 99,970 | -3.4% | 0.00% | -50.0% |
| Q1 2015 | $811,000 | +224.4% | 103,530 | +155.6% | 0.00% | +100.0% |
| Q2 2014 | $250,000 | -7.7% | 40,497 | -2.9% | 0.00% | 0.0% |
| Q1 2014 | $271,000 | +19.9% | 41,691 | +3.9% | 0.00% | 0.0% |
| Q4 2013 | $226,000 | -12.1% | 40,141 | -4.3% | 0.00% | 0.0% |
| Q3 2013 | $257,000 | +2.0% | 41,941 | -2.7% | 0.00% | 0.0% |
| Q2 2013 | $252,000 | – | 43,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $7,725,000 | 6.48% |
| Ghost Tree Capital, LLC | 250,000 | $1,545,000 | 1.09% |
| Rock Springs Capital Management LP | 905,000 | $5,593,000 | 1.00% |
| Palo Alto Investors LP | 1,931,324 | $11,936,000 | 0.89% |
| PFM Health Sciences, LP | 4,604,958 | $28,459,000 | 0.57% |
| NEA Management Company, LLC | 1,935,300 | $11,960,000 | 0.56% |
| Rhenman & Partners Asset Management AB | 300,199 | $1,855,000 | 0.55% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,752,792 | $10,832,000 | 0.50% |
| CQS Cayman LP | 660,040 | $4,079,000 | 0.25% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,684,300 | $16,589,000 | 0.24% |